![A phase I study of sorafenib, oxaliplatin and 2]()
A phase I study of sorafenib, oxaliplatin and 2LoConte, Noelle K.; Holen, Kyle D.; Schelman, William R.; Mulkerin, Daniel L.; Deming, Dustin A.; Hernan, Hilary R.; Traynor, Anne M.; Goggins, Timothy; Groteluschen, David; Oettel, Kurt; Robinson, Emily; Lubner, Sam J. · Investigational New Drugs · 2013